Jeil Pharmaceutical Co.,Ltd. develops and distributes pharmaceutical products. The Company produces solid pharmaceuticals, injections, finished drugs, and antibiotics for the treatment of oncology, urology, neuropsychiatry, and endocrinology. Jeil Pharmaceutical markets its products worldwide.

Decision on Paid-in Capital Increase (Material Business Matters of Subsidiary Company)

[Revised] Conclusion of Single Sales Contract or Supply Contract

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jeil Pharmaceutical (271980 KS)

Decision on Paid-in Capital Increase (Material Business Matters of Subsidiary Company)

[Revised] Conclusion of Single Sales Contract or Supply Contract

Conclusion of Single Sales Contract or Supply Contract

Outcome of Annual Shareholders' Meeting

Submission of Audit Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)